Perspective Therapeutics (CATX) Gross Margin Growth (1y) (2011 - 2023)
Powered by 
Analysis
Perspective Therapeutics (CATX) Gross Margin Growth (1y) (2011 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 484.00 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 96.00 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | -93.00 |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | -91.00 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 210.00 |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 1,966.00 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | -475.00 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -553.00 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 1,034.00 |
| 10 | Perspective Therapeutics | 358.23 Mn | 358.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -522.00 |
| Jun 30, 2023 | -3,183.00 |
| Mar 31, 2023 | -2,591.00 |
| Sep 30, 2022 | -114.00 |
| Jun 30, 2022 | -596.00 |
| Mar 31, 2022 | -287.00 |
| Dec 31, 2021 | -615.00 |
| Sep 30, 2021 | -1,213.00 |
| Jun 30, 2021 | 267.00 |
| Mar 31, 2021 | -685.00 |
| Dec 31, 2020 | -89.00 |
| Sep 30, 2020 | -113.00 |
| Jun 30, 2020 | 131.00 |
| Mar 31, 2020 | 1,355.00 |
| Dec 31, 2019 | 1,018.00 |
| Sep 30, 2019 | 1,984.00 |
| Jun 30, 2019 | 1,805.00 |
| Mar 31, 2019 | 697.00 |
| Dec 31, 2018 | 561.00 |
| Sep 30, 2018 | 1,166.00 |